These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31172600)

  • 21. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel compounds from Piper methysticum Forst (Kava Kava) roots and their effect on cyclooxygenase enzyme.
    Wu D; Nair MG; DeWitt DL
    J Agric Food Chem; 2002 Feb; 50(4):701-5. PubMed ID: 11829631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract.
    He XG; Lin LZ; Lian LZ
    Planta Med; 1997 Feb; 63(1):70-4. PubMed ID: 17252331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J; Kavanagh DJ
    J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
    Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
    Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC).
    Lebot V; Do TK; Legendre L
    Food Chem; 2014 May; 151():554-60. PubMed ID: 24423570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kava extract for treating anxiety.
    Pittler MH; Edzard E
    Cochrane Database Syst Rev; 2001; (4):CD003383. PubMed ID: 11687196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanogenesis stimulation in murine B16 melanoma cells by Kava (Piper methysticum) rhizome extract and kavalactones.
    Matsuda H; Hirata N; Kawaguchi Y; Naruto S; Takata T; Oyama M; Iinuma M; Kubo M
    Biol Pharm Bull; 2006 Apr; 29(4):834-7. PubMed ID: 16595931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kava and its Kavalactones Inhibit Norepinephrine-induced Intracellular Calcium Influx in Lung Cancer Cells.
    Botello JF; Corral P; Bian T; Xing C
    Planta Med; 2020 Jan; 86(1):26-31. PubMed ID: 31711251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
    Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
    J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.
    Showman AF; Baker JD; Linares C; Naeole CK; Borris R; Johnston E; Konanui J; Turner H
    Fitoterapia; 2015 Jan; 100():56-67. PubMed ID: 25464054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biosynthetic origin of psychoactive kavalactones in kava.
    Pluskal T; Torrens-Spence MP; Fallon TR; De Abreu A; Shi CH; Weng JK
    Nat Plants; 2019 Aug; 5(8):867-878. PubMed ID: 31332312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
    Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
    Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells.
    Shimoda LM; Park C; Stokes AJ; Gomes HH; Turner H
    Phytother Res; 2012 Dec; 26(12):1934-41. PubMed ID: 22473598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.